| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Oregon Regional Primate Research Center (R.D.M., K.M., M.A., M.N., K.H.), Departments of Medicine (K.H.), Cell and Developmental Biology (K.H.), and Obstetrics and Gynecology (M.N.), and The Dotter Interventional Institute (B.U.), Oregon Health Sciences University, Portland, Oregon 97201; and the Department of Obstetrics and Gynecology, Women and Childrens Hospital, University of Southern California (F.Z.S.), Los Angeles, California 90033
Address all correspondence and requests for reprints to: Dr. Kent Hermsmeyer, Oregon Regional Primate Research Center, 505 NW 185th Avenue, Beaverton, Oregon 97006.
Our hypothesis was that estrogen and progesterone modulate coronary artery reactivity in rhesus monkeys. Adult ovariectomized (ovx) monkeys were treated for 1, 2, or 4 wk with physiological concentrations of 17ß-estradiol (E2), natural progesterone (P), and/or therapeutic levels of medroxyprogesterone acetate (MPA). Steroid concentrations in venous blood, coronary artery estrogen receptor (ER) and progesterone receptor (PR) localization, and isolated vascular muscle cell (VMC) Ca2+ and protein kinase C responses to serotonin and U46619 (a thromboxane A2 mimetic) were measured. Ovx monkey VMC responses were hyperreactive, showing prolonged increases in intracellular Ca2+ and protein kinase C that correlated with exaggerated in vivo coronary artery vasoconstrictor responses. The hyperreactive Ca2+ responses were abolished by in vivo treatment with E2 and/or P. However, VMC from ovx monkeys treated with the combination of E2 and MPA or E2, P, and MPA remained hyperreactive to vasoconstrictor stimuli, suggesting that MPA negated the protective effects of E2. ER were detected primarily in interstitial and endothelial cells and a minor fraction of the VMC. PR were localized to coronary artery VMC and interstitial cell nuclei. In vivo treatment of ovx monkeys with E2 tended to up-regulate PR in VMC, but MPA appeared to down-regulate PR expression. These results suggest that E2 and P replacement decreases coronary artery reactivity through direct interactions with ER and PR in coronary artery VMC.
This article has been cited by other articles:
![]() |
P. K. Mishra Variations in presentation and various options in management of variant angina. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 748 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Mishra, F. Z. Stanczyk, K. A. Burry, S. Oparil, B. S. Katzenellenbogen, M. L. Nealen, J. A. Katzenellenbogen, and R. K. Hermsmeyer Metabolite ligands of estrogen receptor-{beta} reduce primate coronary hyperreactivity Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H295 - H303. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Mishra, R. K. Hermsmeyer, K. Miyagawa, P. Sarrel, B. Uchida, F. Z. Stanczyk, K. A. Burry, D. R. Illingworth, and F. J. Nordt Medroxyprogesterone Acetate and Dihydrotestosterone Induce Coronary Hyperreactivity in Intact Male Rhesus Monkeys J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3706 - 3714. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hermenegildo, P.J. Oviedo, M.C. Garcia-Martinez, M.A. Garcia-Perez, J.J. Tarin, and A. Cano Progestogens stimulate prostacyclin production by human endothelial cells Hum. Reprod., June 1, 2005; 20(6): 1554 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Hermsmeyer, R. G. Mishra, D. Pavcnik, B. Uchida, M. K. Axthelm, F. Z. Stanczyk, K. A. Burry, D. R. Illingworth, J. C. Kaski, and F. J. Nordt Prevention of Coronary Hyperreactivity in Preatherogenic Menopausal Rhesus Monkeys by Transdermal Progesterone Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 955 - 961. [Abstract] [Full Text] |
||||
![]() |
B. H. Welter, E. L. Hansen, K. J. Saner, Y. Wei, and T. M. Price Membrane-bound Progesterone Receptor Expression in Human Aortic Endothelial Cells J. Histochem. Cytochem., August 1, 2003; 51(8): 1049 - 1055. [Abstract] [Full Text] |
||||
![]() |
A. M. McNeill, C. Zhang, F. Z. Stanczyk, S. P. Duckles, and D. N. Krause Estrogen Increases Endothelial Nitric Oxide Synthase via Estrogen Receptors in Rat Cerebral Blood Vessels: Effect Preserved After Concurrent Treatment With Medroxyprogesterone Acetate or Progesterone Stroke, June 1, 2002; 33(6): 1685 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Minshall, D. Pavcnik, D. L. Browne, and K. Hermsmeyer Nongenomic vasodilator action of progesterone on primate coronary arteries J Appl Physiol, February 1, 2002; 92(2): 701 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Minshall, D. Pavcnik, P. V. Halushka, and K. Hermsmeyer Progesterone regulation of vascular thromboxane A2 receptors in rhesus monkeys Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1498 - H1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Mather, E. G. Norman, J. C. Prior, and T. G. Elliott Preserved Forearm Endothelial Responses with Acute Exposure to Progesterone: A Randomized Cross-Over Trial of 17-{beta} Estradiol, Progesterone, and 17-{beta} Estradiol with Progesterone in Healthy Menopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4644 - 4649. [Abstract] [Full Text] |
||||
![]() |
X. Zhu, B. Bonet, H. Gillenwater, and R. H. Knopp Opposing Effects of Estrogen and Progestins on LDL Oxidation and Vascular Wall Cytotoxicity: Implications for Atherogenesis Experimental Biology and Medicine, December 1, 1999; 222(3): 214 - 221. [Abstract] [Full Text] |
||||
![]() |
H. B. LEONETTI, S. LONGO, and J. N. ANASTI Transdermal Progesterone Cream for Vasomotor Symptoms and Postmenopausal Bone Loss Obstet. Gynecol., August 1, 1999; 94(2): 225 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barrett-Connor and C. Stuenkel Hormones and Heart Disease in Women: Heart and Estrogen/Progestin Replacement Study in Perspective J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1848 - 1853. [Full Text] |
||||
![]() |
R. D. Minshall, K. Miyagawa, C. C. Chadwick, M. J. Novy, and K. Hermsmeyer In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones FASEB J, October 1, 1998; 12(13): 1419 - 1429. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |